A recent Supreme Court ruling has raised concerns within the pharmaceutical industry, potentially complicating future operations and strategies.
In addition to the legal challenges, TrumpRx is reportedly experiencing growth, suggesting a shift in the competitive landscape of the pharmaceutical market.
These developments reflect ongoing tensions and changes in the healthcare sector, with implications for both companies and consumers.